DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
PF-06372865 is an investigational drug.
There have been 10 clinical trials for PF-06372865. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Disease, Anxiety Disorders, and Low Back Pain. The leading clinical trial sponsors are Pfizer and [disabled in preview].
There is one US patent protecting this investigational drug and forty-eight international patents.
Recent Clinical Trials for PF-06372865
|A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects||Pfizer||Phase 1|
|PF-06372865 in Subjects With Photosensitive Epilepsy||Pfizer||Phase 2|
|An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects||Pfizer||Phase 1|
Top disease conditions for PF-06372865
Top clinical trial sponsors for PF-06372865
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|